KRYSTAL BIOTECH, INC. (KRYS)

Clinical trial NCT01837862 updates: 1. status: COMPLETED → ACTIVE_NOT_RECRUITING 2. completion date: 2024-04-01 → 2027-12-01 3. primary completion date: 2024-04-01 → 2027-03-01 4. enrollment: 36 → 10 participants 5. enrollment type: ESTIMATED → ACTUAL

NUVECTIS PHARMA, INC. (NVCT)

Clinical trial NCT05226507 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-12-01 → 2025-01-01 3. primary completion date: 2025-12-01 → 2025-01-01 4. collaborators added: European Network of Gynaecological Oncological Trial Groups (ENGOT) 5. collaborators removed: The European Network for Gynaecological Oncological Trial groups (ENGOT)